Oric Pharmaceuticals Stock Current Valuation
| ORIC Stock | USD 7.03 0.48 6.39% |
Valuation analysis of Oric Pharmaceuticals helps investors to measure Oric Pharmaceuticals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Oric Pharmaceuticals' price fluctuation is relatively risky at this time. Calculation of the real value of Oric Pharmaceuticals is based on 3 months time horizon. Increasing Oric Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Oric Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oric Stock. However, Oric Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.03 | Real 6.75 | Hype 7.03 | Naive 6.52 |
The real value of Oric Stock, also known as its intrinsic value, is the underlying worth of Oric Pharmaceuticals Company, which is reflected in its stock price. It is based on Oric Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Oric Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Oric Pharmaceuticals helps investors to forecast how Oric stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oric Pharmaceuticals more accurately as focusing exclusively on Oric Pharmaceuticals' fundamentals will not take into account other important factors: Oric Pharmaceuticals Company Current Valuation Analysis
Oric Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Oric Pharmaceuticals Current Valuation | 246.19 M |
Most of Oric Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oric Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Oric Pharmaceuticals has a Current Valuation of 246.19 M. This is 98.29% lower than that of the Biotechnology sector and 94.7% lower than that of the Health Care industry. The current valuation for all United States stocks is 98.52% higher than that of the company.
Oric Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oric Pharmaceuticals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Oric Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Oric Pharmaceuticals by comparing valuation metrics of similar companies.Oric Pharmaceuticals is currently under evaluation in current valuation category among its peers.
Oric Fundamentals
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.34 | ||||
| Current Valuation | 246.19 M | ||||
| Shares Outstanding | 71.03 M | ||||
| Shares Owned By Insiders | 9.43 % | ||||
| Shares Owned By Institutions | 90.57 % | ||||
| Number Of Shares Shorted | 12.04 M | ||||
| Price To Book | 2.05 X | ||||
| EBITDA | (142.9 M) | ||||
| Net Income | (127.85 M) | ||||
| Cash And Equivalents | 227.06 M | ||||
| Cash Per Share | 5.74 X | ||||
| Total Debt | 3.18 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 18.72 X | ||||
| Book Value Per Share | 3.42 X | ||||
| Cash Flow From Operations | (112.66 M) | ||||
| Short Ratio | 8.51 X | ||||
| Earnings Per Share | (1.83) X | ||||
| Target Price | 19.08 | ||||
| Number Of Employees | 115 | ||||
| Beta | 1.25 | ||||
| Market Capitalization | 533.79 M | ||||
| Total Asset | 274.14 M | ||||
| Retained Earnings | (562.77 M) | ||||
| Working Capital | 237.4 M | ||||
| Net Asset | 274.14 M |
About Oric Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oric Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oric Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oric Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Oric Pharmaceuticals Piotroski F Score and Oric Pharmaceuticals Altman Z Score analysis. For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oric Pharmaceuticals. If investors know Oric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oric Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oric Pharmaceuticals is measured differently than its book value, which is the value of Oric that is recorded on the company's balance sheet. Investors also form their own opinion of Oric Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oric Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oric Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oric Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oric Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oric Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oric Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.